LAPORTE KATHLEEN
Insider CIK 1196201 · PRPO Director · AFFY Director · TSPT Director · BOLT Director · QTTB Director · ETNB Director · PBAX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-07-21 | 10,826 | — | $0 | 10,826 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 9,810 | — | $0 | 9,810 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 5,000 | — | $0 | 5,000 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2026-01-15 | 2026-01-30 | 23,272 | $2.75 | $64.0K | 23,272 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2026-01-15 | 2026-01-20 | 520 | $24.00 | $12.5K | 7,382 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2026-01-07 | 2026-01-09 | 690,900 | — | $0 | 690,900 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 1,500 | — | $0 | 1,500 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,250 | — | $0 | 1,250 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,250 | — | $0 | 1,250 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 1,250 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,100 | — | $0 | 1,100 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 1,100 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,100 | — | $0 | 1,100 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 1,100 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 1,250 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,250 | — | $0 | 1,250 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 1,250 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,250 | — | $0 | 1,250 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 1,250 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | D To issuer deriv | 2025-12-12 | 2025-12-16 | 1,392 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 1,392 | — | $0 | 1,392 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 56,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 45,150 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 12,500 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 27,400 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-10-23 | 2025-10-27 | 53,521 | — | $0 | 53,521 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2025-10-15 | 2025-10-16 | 711 | $17.58 | $12.5K | 6,862 | SEC↗ |
| PRPO Precipio, Inc. | S Sale | 2025-09-08 | 2025-09-10 | 6,152 | $20.06 | $123.4K | 6,151 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-05-30 | 2025-06-02 | 9,326 | — | $0 | 9,326 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2025-05-27 | 2025-07-02 | 1,100 | — | $0 | 1,100 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2025-04-15 | 2025-04-17 | 2,232 | $5.60 | $12.5K | 12,303 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-03-04 | 2025-03-06 | 17,923 | — | $0 | 17,923 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-02-24 | 2025-02-26 | 127,500 | — | $0 | 255,000 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-27 | 5,431 | — | $0 | 5,431 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-27 | 5,431 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-27 | 1,947 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-27 | 1,947 | — | $0 | 1,947 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-27 | 12,767 | — | $0 | 12,767 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-27 | 12,767 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 56,400 | — | $0 | 56,400 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2025-01-14 | 2025-01-16 | 1,000 | — | $0 | 1,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-12-02 | 2024-12-04 | 127,500 | — | $0 | 127,500 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise deriv | 2024-09-25 | 2024-10-02 | 50 | $1000.00 | $50.0K | 0 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | M Exercise | 2024-09-25 | 2024-10-02 | 965,997 | — | $0 | 965,997 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 75 | — | $0 | 75 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 2,000 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 1,250 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 1,250 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 200 | — | $0 | 200 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 200 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 375 | — | $0 | 375 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 375 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 70 | — | $0 | 70 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 70 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 28 | — | $0 | 28 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 28 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 250 | — | $0 | 250 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 250 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 188 | — | $0 | 188 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 188 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-08-31 | 2024-09-06 | 2,000 | — | $0 | 2,000 | SEC↗ |
| PRPO Precipio, Inc. | D To issuer deriv | 2024-08-31 | 2024-09-06 | 75 | — | $0 | 0 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 1,000 | — | $0 | 1,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 22,000 | — | $0 | 22,000 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2024-04-15 | 2024-04-17 | 9,693 | $6.70 | $64.9K | 10,071 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2024-03-25 | 2024-03-27 | 12,767 | — | $0 | 12,767 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-03-25 | 2024-03-27 | 112,500 | — | $0 | 112,500 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-02-14 | 2024-02-16 | 50 | $1000.00 | $50.0K | 50 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-02-14 | 2024-02-21 | 50 | $1000.00 | $50.0K | 50 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 5,828 | — | $0 | 5,828 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 45,150 | — | $0 | 45,150 | SEC↗ |
| PRPO Precipio, Inc. | A Award | 2023-09-12 | 2023-09-14 | 7,575 | — | $0 | 7,575 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise deriv | 2023-07-17 | 2023-07-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2023-07-17 | 2023-07-18 | 12,500 | $18.80 | $235.0K | 0 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise | 2023-07-17 | 2023-07-18 | 12,500 | $2.64 | $33.0K | 12,500 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2023-06-12 | 2023-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2023-02-09 | 2023-02-13 | 27,400 | — | $0 | 27,400 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2023-01-06 | 2023-01-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2022-12-14 | 2022-12-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2022-06-10 | 2022-06-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2022-05-16 | 2022-05-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2022-03-24 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2022-01-11 | 2022-01-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2021-11-01 | 2021-11-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PBAX PHOENIX BIOTECH ACQUISITIO | J Other deriv | 2021-10-08 | 2021-10-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2021-08-03 | 2021-08-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 1,200 | $20.00 | $24.0K | 1,200 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2021-01-04 | 2021-01-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2020-07-02 | 2020-07-06 | 4,000 | — | $0 | 4,000 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2020-01-16 | 2020-01-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2019-04-17 | 2019-04-22 | 21,163 | — | $0 | 21,163 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2019-04-17 | 2019-04-22 | 8,465 | — | $0 | 8,465 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2019-03-18 | 2019-03-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2018-08-07 | 2018-08-13 | 56,400 | — | $0 | 56,400 | SEC↗ |
| PRPO Precipio, Inc. | A Award deriv | 2018-08-07 | 2018-08-13 | 22,560 | — | $0 | 22,560 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-12-14 | 2012-12-18 | 2,500 | — | $0 | 0 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-12-14 | 2012-12-18 | 2,500 | — | $0 | 0 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-12-14 | 2012-12-18 | 2,500 | $16.79 | $42.0K | 5,000 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-12-14 | 2012-12-18 | 2,500 | $14.24 | $35.6K | 2,500 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-12-14 | 2012-12-18 | 5,000 | $22.72 | $113.6K | 0 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2012-06-13 | 2012-06-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2012-01-24 | 2012-01-26 | 7,000 | — | $0 | 7,000 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2012-01-24 | 2012-02-02 | 7,000 | — | $0 | 7,000 | SEC↗ |